Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -79.20% is 94% below its 5-year average of -40.76%, near the low end of its 5-year range (-79.20%–-23.02%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.83% below its 12-month average of -66.10%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -79.20%.
RETURN ON INVESTED CAPITAL (ROIC)
-79.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-66.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-48.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-40.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-19.83%
CURRENT VS 3Y AVG
-62.08%
CURRENT VS 5Y AVG
-94.29%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-122.10%
vs the sector median at left
TScan Therapeutics, Inc.
Market Cap
$16.82M
Return on Invested Capital (ROIC)
-79.20%
TTM Avg
-66.10%
3Y Avg
-48.86%
5Y Avg
-40.76%
Market Cap
$16.84M
Return on Invested Capital (ROIC)
-88.07%
TTM Avg
-68.32%
3Y Avg
-78.67%
5Y Avg
-76.64%
Market Cap
$16.74M
Return on Invested Capital (ROIC)
-125.44%
TTM Avg
-125.44%
3Y Avg
-1118.57%
5Y Avg
-719.84%
Market Cap
$16.64M
Return on Invested Capital (ROIC)
-85.72%
TTM Avg
-120.02%
3Y Avg
-101.35%
5Y Avg
-83.66%
Market Cap
$17.07M
Return on Invested Capital (ROIC)
-73.92%
TTM Avg
-122.57%
3Y Avg
-184.65%
5Y Avg
-161.38%
Market Cap
$16.52M
Return on Invested Capital (ROIC)
-279.48%
TTM Avg
-96.52%
3Y Avg
-105.30%
5Y Avg
-89.17%
Market Cap
$17.31M
Return on Invested Capital (ROIC)
-57.74%
TTM Avg
-38.37%
3Y Avg
-49.64%
5Y Avg
-45.59%
Market Cap
$17.39M
Return on Invested Capital (ROIC)
-46.69%
TTM Avg
-40.71%
3Y Avg
-34.73%
5Y Avg
-24.39%
Market Cap
$15.78M
Return on Invested Capital (ROIC)
-273.70%
TTM Avg
-707.06%
3Y Avg
-535.27%
5Y Avg
-358.40%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TScan Therapeutics, Inc. (TCRX) | $16.82M | -79.20% | -66.10% | -48.86% | -40.76% |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | -88.07% | -68.32% | -78.67% | -76.64% |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | -125.44% | -125.44% | -1118.57% | -719.84% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -85.72% | -120.02% | -101.35% | -83.66% |
| PAVmed Inc. (PAVM)vs › | $17.07M | -73.92% | -122.57% | -184.65% | -161.38% |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | -279.48% | -96.52% | -105.30% | -89.17% |
| Lipocine Inc. (LPCN)vs › | $17.31M | -57.74% | -38.37% | -49.64% | -45.59% |
| Cosmos Health Inc. (COSM)vs › | $17.39M | -46.69% | -40.71% | -34.73% | -24.39% |
| BioCardia, Inc. (BCDA)vs › | $15.78M | -273.70% | -707.06% | -535.27% | -358.40% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | -41.81% | -159.62% | -298.97% | -203.41% |
ROIC
-79.2%
ROE
-170.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -79.20% |
| 2026-03-31 | -70.71% |
| 2025-12-31 | -64.64% |
| 2025-09-30 | -61.96% |
| 2025-06-30 | -53.97% |
| 2025-03-31 | -46.12% |
| 2024-12-31 | -40.23% |
| 2024-09-30 | -37.41% |
| 2024-06-30 | -31.86% |
| 2024-03-31 | -47.23% |
| 2023-12-31 | -38.04% |
| 2023-09-30 | -34.99% |
| 2023-06-30 | -28.87% |
| 2023-03-31 | -45.89% |
| 2022-12-31 | -35.93% |
| 2022-09-30 | -41.78% |
| 2022-06-30 | -45.44% |
| 2022-03-31 | -37.99% |
| 2021-12-31 | -28.88% |
| 2021-09-30 | -23.02% |
| 2021-06-30 | -30.26% |
| 2021-03-31 | -23.06% |
| 2020-12-31 | -81.24% |
